May 2020

The Science of COVID-19

COVID-19 has proved a formidable foe in the clinic and a source of scientific mystery. Around the University, researchers are tackling a number of unanswered questions, from investigating the toll it takes on the lungs to pinpointing the optimal time to intervene with social distancing measures. Their work is aimed at finding rapid application in the crisis. “It’s one of the beautiful things about Penn,” says John Wherry, PhD, of the Perelman School of Medicine. “Everyone is working as a team.” 
Read more

Cancer Patients and COVID-19

Basser researcher and Penn Medicine oncologist Kim Reiss Binder, MD, shares the difficulty of treating cancer patients during the pandemic with the Philadelphia Inquirer. "As our patients have taught us, we must continue to hope for a brighter tomorrow."
Dr. Reiss Binder has recently been awarded both the Pearl and Philip Basser Innovation Research Award and the Basser Young Leadership Council's Young Investigator Award. Her groundbreaking research includes a recent PARP inhibitor trial for BRCA-related pancreatic cancer. 

Mother and Daughter Duo Beat Breast Cancer

The Basser Center was a proud sponsor of the 4th Annual #Cancerland New York Fashion Week Fundraiser fashion show featuring AnaOno and benefiting METAvivor Research and Support Inc. 

Replacing Fear with Hope

As part of our LATINX & BRCA initiative to raise awareness of hereditary cancer, provide education and resources, and build community for the U.S. Latinx community around BRCA-related cancers, we've translated our most recent animated video into Spanish.

Basser Center Research Round Up

EMBRACA Trial Shows No Overall Survival Difference Between Talzenna, Chemotherapy Arms
At the American Association for Cancer Research’s virtual annual meeting, Basser Executive Director Susan Domchek, MD, discussed the EMBRACA trial, which examined the PARP inhibitor talazoparib and its impact on BRCA-related breast cancer treatment.
Breast MRI in the Lactating Patient: A Single Center Experience
For the SBI/ACR Breast Imaging Symposium, Penn Medicine's Sophia O'Brien, MD, presents her award-winning abstract on breast MRI screening for BRCA mutation carriers who are breast feeding.
DONATE SPREAD THE WORD CONTACT BASSER
Basser Center
 
Facebook Twitter Instagram
basser.org | 215.662.2748
Manage your preferences | Opt out using TrueRemove®
Got this as a forward? Sign up to receive our future emails.
View this email online.
This email was sent to samantha.deighan@uphs.upenn.edu.
Continue receiving our emails, add us to your address book.